First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis.
Ther Adv Neurol Disord
; 16: 17562864231162153, 2023.
Article
in En
| MEDLINE
| ID: mdl-36993937
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Ther Adv Neurol Disord
Year:
2023
Document type:
Article
Affiliation country:
Japón